Search results for “Programmed cell death” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,278 patents, we discovered top 274 key players by total patent application. Exelixis, Inc., Regeneron Pharmaceuticals, Inc., Aurigene Discovery Technologies Ltd. are dominant in this area. They take 15.88% of the total patent filing.
Exelixis, Inc.
California, United States
Patent: 107
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 49
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 47
ARCH Development Corp.
District of Columbia, United States
Patent: 30
Shanghai Henlius Biotech, Inc.
Shanghai Shi, China
Patent: 24
The General Hospital Corp.
Massachusetts, United States
Patent: 22
Senesco Technologies Inc.
Idaho, United States
Patent: 21
Sanofi SA
France
Patent: 20
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 19
Immutep SAS
France
Patent: 16
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 49 patents, we discovered top 12 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Eterna Therapeutics LLC, Eucure (Beijing) Biopharma Co., Ltd. are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 15
STARTUP
Eterna Therapeutics LLC
New York, United States
Patent: 6
STARTUP
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 6
STARTUP
Tusk Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 6
STARTUP
Agribody Technologies, Inc.
California, United States
Patent: 6
STARTUP
Bicara Therapeutics
Massachusetts, United States
Patent: 2
STARTUP
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 2
STARTUP
AiVita Biomedical, Inc.
California, United States
Patent: 2
STARTUP
OriCell Therapeutics Co.,Ltd.
China
Patent: 1
STARTUP
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 657 patents applied in the last 5 years. We discover 233 most active companies in this area. The fast-growing Shanghai Henlius Biotech, Inc., Sanofi SA, Regeneron Pharmaceuticals, Inc. take 9.28% of patent filing during this period.
Shanghai Henlius Biotech, Inc.
Shanghai Shi, China
Patent: 22
Sanofi SA
France
Patent: 20
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 19
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 16
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 15
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 15
Centre National De La Recherche Scientif
France
Patent: 14
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 14
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 14
Crescendo Biologics Ltd.
Cambridgeshire, United Kingdom
Patent: 13
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 657 patents in last 5 years, we discover 168 new entrants. Sanofi SA, Merck Sharp & Dohme Corp., Icahn School of Medicine at Mount Sinai are the most active new entrants in this area.
Sanofi SA
France
Patent: 20
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 15
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 14
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 14
Crescendo Biologics Ltd.
Cambridgeshire, United Kingdom
Patent: 13
Mayo Foundation for Medical Education & Research
Minnesota, United States
Patent: 12
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 11
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 10
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 10
Université Paris-Saclay
CENTRE COUNTY, France
Patent: 9
Research Institutions
Order by:
Innovation Intensity
With the analysis among 492 patents, we discovered top 96 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Emory University, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 23.37% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 38
Emory University
Georgia, United States
Patent: 22
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 14
The Johns Hopkins University
United States
Patent: 13
Sorbonne Université
France
Patent: 9
Université Paris-Saclay
CENTRE COUNTY, France
Patent: 9
Yale University
Connecticut, United States
Patent: 8
University of Washington
Washington, United States
Patent: 8
University of Wollongong
New South Wales, Australia
Patent: 8
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 8
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: